Research Articles
The Work-Cancer Link: How Your Job Can Influence Breast Cancer Risk
Exploring how occupational factors and socioeconomic status affect breast cancer risk and diagnosis in Swiss working women
The Hidden Army: How Scientists Hunt Breast Cancer's "Sleeper Cells"
Discover how scientists detect disseminated tumor cells in breast cancer patients and why these 'sleeper cells' matter for cancer recurrence.
A New Two-Pronged Attack on an Aggressive Breast Cancer
Scientists explore combination therapy targeting AURKA and AURKB proteins to combat triple-negative breast cancer, focusing on health disparities in women of African ancestry.
The Hidden Architects of Cancer's Spread: Unmasking the Culprits in Early-Stage Breast Cancer
Discover how S100A4 and Osteopontin proteins influence metastasis in minimally invasive breast cancer and their potential as prognostic biomarkers.
A Different Enemy: Unraveling the Mystery of Breast Cancer in Nigerian Women
Exploring the clinical and biological differences in breast cancer between Nigerian and UK women, focusing on molecular subtypes and genetic factors.
The Unseen Invaders: A New Hunt for Breast Cancer's Culprits
How scientists are using a novel, cell-based approach to pinpoint the chemicals in our environment that may be driving cancer risk.
The Hidden Clock: How Treatment Delays Impact Breast Cancer Survival
Exploring how treatment delays affect breast cancer survival rates and the critical 42-day tipping point for surgery.
How Deep Neural Networks Are Revolutionizing Breast Cancer Detection
Explore how deep neural networks are transforming breast cancer detection with improved accuracy, earlier diagnosis, and AI-powered medical imaging.
Decoding the Hidden Landscape: How Breast Cancer Biology Differs Across Racial and Ethnic Groups
Exploring racial and ethnic differences in breast tumor biology and the immune microenvironment through multiethnic cohort studies.
Cracking Cancer's Code: The Protein Detectives Guiding Breast Cancer Treatment
Discover how immunoenzymatic assays for HER2 and EGFR proteins revolutionized breast cancer treatment through personalized medicine approaches.